As part of Slovenia’s strategic efforts to strengthen international cooperation in the life sciences, a high-level business delegation will visit Basel, Switzerland on 8 September 2025. This initiative aims to promote Slovenia’s pharmaceuticals and biotech ecosystem and foster new partnerships in research, development, and commercialization.
8 September 2025
10:00 - 17:00
With globally competitive pharmaceutical companies, a strong emphasis on research and innovation, strategic geographic positioning, and government support for international collaboration and investment, Slovenia is steadily reinforcing its role in Europe’s healthcare and biotech landscape. Switzerland has become Slovenia’s top trade partner in 2024, driven largely by the pharmaceutical sector with a focus on the long-standing presence of Novartis and its generics division Sandoz, which acquired Slovenian pharma company Lek. This deep integration highlights the strategic importance of Slovenia in the Swiss pharmaceutical supply chain.
The delegation is organized by SPIRIT Slovenia Business Development Agency, the Ministry of Economy, Tourism and Sport, the Embassy of the Republic of Slovenia in Switzerland, and the Biotech Hills Institute.
SPIRIT Slovenia Business Development Agency provides support to Slovenian exporters, foreign companies looking for Slovenian business partners and potential foreign investors interested in investment opportunities in Slovenia. For more information contact us.
